Precision therapy in pancreatic cancer: from streamlet towards mainstream
Pancreatic cancer is a highly dismal malignancy and has a poor response to major treatments. Patients with pancreatic cancer usually have poor prognosis. Precision therapy has a great potential to improve the outcome of pancreatic cancer. Over 25% of patients have druggable targets, which mainly inv...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Editorial Office of China Oncology
2022-11-01
|
| Serija: | Zhongguo aizheng zazhi |
| Teme: | |
| Online pristup: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2022.10.004 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|